Altered Regulation of HIF-1α in Naive- and Drug-Resistant EGFR-Mutant NSCLC: Implications for a Vascular Endothelial Growth Factor-Dependent Phenotype.
Journal Of Thoracic Oncology : Official Publication Of The International Association For The Study Of Lung Cancer
Nilsson, Monique B MB; Robichaux, Jacqulyne J; Herynk, Matthew H MH; Cascone, Tina T; Le, Xiuning X; Elamin, Yasir Y; Patel, Sonia S; Zhang, Fahao F; Xu, Li L; Hu, Limei L; Diao, Lixia L; Shen, Li L; He, Junqin J; Yu, Xiaoxing X; Nikolinakos, Petros P; Saintigny, Pierre P; Fang, Bingliang B; Girard, Luc L; Wang, Jing J; Minna, John D JD; Wistuba, Ignacio I II; Heymach, John V JV
Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT).
Plos One
De Grève, Jacques J; Van Meerbeeck, Jan J; Vansteenkiste, Johan F JF; Decoster, Lore L; Meert, Anne-Pascale AP; Vuylsteke, Peter P; Focan, Christian C; Canon, Jean-Luc JL; Humblet, Yves Y; Berchem, Guy G; Colinet, Benoit B; Galdermans, Danny D; Bosquée, Lionel L; Vermeij, Joanna J; Dewaele, Alex A; Geers, Caroline C; Schallier, Denis D; Teugels, Erik E